Search

everythinglearnresearchcommunity

for

Search:↓

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

A horse in Brazil had seasonal hair loss possibly linked to light exposure and melatonin levels.

Sweat hypersensitivity can cause severe skin issues in horses.